Clinical Trial Results:
Predictive value of baseline and stimulated serum IGF-I and IGFBP-3 during a dose-escalation IGF-I generation test with NutropinAq for the 1 year growth response to growth hormone (GH) therapy in short children with low IGF-I and a normal GH peak in a provocation test
Summary
|
|
EudraCT number |
2010-019980-13 |
Trial protocol |
NL |
Global completion date |
31 May 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
18 Aug 2019
|
First version publication date |
04 May 2019
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
Study summary_2010-019980-13 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.